Pancreatic Cancer Research

ResearcherUniversity of Campania "Luigi Vanvitelli"No recent work listed

Ciro Gallo

Matched on ORCID iD 0000-0002-7939-3104; OpenAlex author ID A5016655393. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2002: 1 trial · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 1

  1. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomi… Co-author DOI 10.1016/j.ejca.2021.02.023↗

Trials 1

  1. Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer Principal investigator NCT00813696↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Spallanzani · 1 shared paper, 2021 · strength 0.09
  2. Roberto Labianca · 1 shared paper, 2021 · strength 0.09
  3. Alessandro Bittoni · 1 shared paper, 2021 · strength 0.09
  4. Stefania Mosconi · 1 shared paper, 2021 · strength 0.09
  5. Rossana Berardi · 1 shared paper, 2021 · strength 0.09
  6. Francesco Perrone · 1 shared paper, 2021 · strength 0.09
  7. Roberto Bianco · 1 shared paper, 2021 · strength 0.09
  8. Alberto Zaniboni · 1 shared paper, 2021 · strength 0.09
  9. Stefano Cascinu · 1 shared paper, 2021 · strength 0.09
  10. Paolo Pederzoli · 1 shared trial, 2002 · strength 0.01
  11. Francesco Di Costanzo · 1 shared trial, 2002 · strength 0.01
  12. Roberto Labianca · 1 shared trial, 2002 · strength 0.01
  13. Giuseppe Colucci · 1 shared trial, 2002 · strength 0.01
  14. Francesco Perrone · 1 shared trial, 2002 · strength 0.01
  15. Stefano Cascinu · 1 shared trial, 2002 · strength 0.01

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.